PPTA's North America division is actively engaged in setting an advocacy and priority agenda for patient access. Staff monitors pending legislation, informs government representatives and works diligently to advance positions that protect the interests of patients who rely on life-saving, plasma protein therapies (PPTs). The Federal Affairs advocates with Members of Congress and Congressional staff on legislative issues related to PPTs, access to therapies and reimbursement. The Association also works in state capitals throughout the U.S. to ensure patient access to therapies, reimbursement and implementation of the Affordable Care Act (ACA).
In North America, PPTA advocates on behalf of patients not only at the state and federal level in the United States but also in Canada:
PPTA is Proud to Support Rare Disease Day 2017 +
The Plasma Protein Therapeutics Association (PPTA) is proud to support Rare Disease Day, an annual international event that seeks to raise awareness about rare diseases and the patients and families that are affected by a rare disease.Read More
PPTA Statement on the Documentary “Das Geschäft mit dem Blut” +
PPTA has viewed the documentary "Das Geschäft mit dem Blut" / "Le business du sang" (http://future.arte.tv/fr/le-business-du-sang) that will air on Feb. 21, 2017 in Germany, France, and Belgium on ARTE TV. PPTA strongly objects to the content of the documentary because it is not factual and contains numerous inaccuracies and misinformation.Read More
PPTA Remembers Corey Dubin +
The Plasma Protein Therapeutics Association (PPTA) notes with sadness the passing of Corey Dubin, President Emeritus of the Committee of Ten Thousand and longtime advocate in the hemophilia community.Read More